Valneva SE (0OB3.L)
EUR 3.15
(4.24%)
EUR 3.15
(4.24%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 44.46 Million EUR | 26.67% |
| 2022 | 35.1 Million EUR | -71.71% |
| 2021 | 124.09 Million EUR | 360.77% |
| 2020 | 26.93 Million EUR | 4.5% |
| 2019 | 25.77 Million EUR | 13.4% |
| 2018 | 22.72 Million EUR | 14.03% |
| 2017 | 19.93 Million EUR | -12.2% |
| 2016 | 22.7 Million EUR | -14.94% |
| 2015 | 26.68 Million EUR | 266.48% |
| 2014 | 7.28 Million EUR | 51.11% |
| 2013 | 4.81 Million EUR | 423.24% |
| 2012 | 921 Thousand EUR | -3.15% |
| 2011 | 951 Thousand EUR | 59.83% |
| 2010 | 595 Thousand EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | -100.0% |
| 2007 | 249 Thousand EUR | 39.11% |
| 2006 | 179 Thousand EUR | -26.03% |
| 2005 | 242 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 48.58 Million EUR | 9.26% |
| 2024 Q2 | 48.86 Million EUR | 0.58% |
| 2023 Q2 | 33.35 Million EUR | -14.48% |
| 2023 Q3 | 38 Million EUR | 13.93% |
| 2023 FY | 44.46 Million EUR | 26.67% |
| 2023 Q1 | 38.99 Million EUR | 11.1% |
| 2023 Q4 | 44.46 Million EUR | 17.02% |
| 2022 Q3 | 96.46 Million EUR | 1.32% |
| 2022 FY | 35.1 Million EUR | -71.71% |
| 2022 Q1 | 139.72 Million EUR | 12.59% |
| 2022 Q2 | 95.2 Million EUR | -31.87% |
| 2022 Q4 | 35.1 Million EUR | -63.61% |
| 2021 Q2 | 125.66 Million EUR | 29.02% |
| 2021 FY | 124.09 Million EUR | 360.77% |
| 2021 Q4 | 124.09 Million EUR | 0.0% |
| 2021 Q1 | 97.4 Million EUR | 261.64% |
| 2020 FY | 26.93 Million EUR | 4.5% |
| 2020 Q1 | 28.11 Million EUR | 9.1% |
| 2020 Q2 | 30.49 Million EUR | 8.45% |
| 2020 Q3 | 28.39 Million EUR | -6.89% |
| 2020 Q4 | 26.93 Million EUR | -5.15% |
| 2019 Q3 | 26.98 Million EUR | 9.75% |
| 2019 FY | 25.77 Million EUR | 13.4% |
| 2019 Q2 | 24.58 Million EUR | 5.77% |
| 2019 Q1 | 23.24 Million EUR | 2.29% |
| 2019 Q4 | 25.77 Million EUR | -4.5% |
| 2018 Q4 | 22.72 Million EUR | -1.12% |
| 2018 Q2 | 20.2 Million EUR | 4.93% |
| 2018 Q1 | 19.25 Million EUR | -3.38% |
| 2018 FY | 22.72 Million EUR | 14.03% |
| 2018 Q3 | 22.98 Million EUR | 13.75% |
| 2017 Q2 | 20.8 Million EUR | 3.29% |
| 2017 Q4 | 19.93 Million EUR | -14.97% |
| 2017 Q3 | 23.44 Million EUR | 12.64% |
| 2017 FY | 19.93 Million EUR | -12.2% |
| 2017 Q1 | 20.14 Million EUR | -11.26% |
| 2016 FY | 22.7 Million EUR | -14.94% |
| 2016 Q2 | 24.01 Million EUR | 9.6% |
| 2016 Q4 | 22.7 Million EUR | -8.29% |
| 2016 Q3 | 24.75 Million EUR | 3.09% |
| 2016 Q1 | 21.91 Million EUR | -17.9% |
| 2015 FY | 26.68 Million EUR | 266.48% |
| 2015 Q1 | 30.31 Million EUR | 316.29% |
| 2015 Q2 | 31.12 Million EUR | 2.66% |
| 2015 Q3 | 29.32 Million EUR | -5.78% |
| 2015 Q4 | 26.68 Million EUR | -8.98% |
| 2014 FY | 7.28 Million EUR | 51.11% |
| 2014 Q1 | 6.37 Million EUR | 32.21% |
| 2014 Q2 | 9.19 Million EUR | 44.33% |
| 2014 Q4 | 7.28 Million EUR | -19.08% |
| 2014 Q3 | 8.99 Million EUR | -2.13% |
| 2013 FY | 4.81 Million EUR | 423.24% |
| 2013 Q4 | 4.81 Million EUR | -27.84% |
| 2013 Q3 | 6.67 Million EUR | -20.03% |
| 2013 Q2 | 8.35 Million EUR | 0.0% |
| 2013 Q1 | - EUR | -100.0% |
| 2012 Q2 | 902 Thousand EUR | 0.0% |
| 2012 Q4 | 921 Thousand EUR | 0.0% |
| 2012 FY | 921 Thousand EUR | -3.15% |
| 2011 FY | 951 Thousand EUR | 59.83% |
| 2011 Q2 | 737 Thousand EUR | 0.0% |
| 2011 Q4 | 951 Thousand EUR | 0.0% |
| 2010 Q2 | 609 Thousand EUR | 0.0% |
| 2010 FY | 595 Thousand EUR | 0.0% |
| 2010 Q4 | 595 Thousand EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | -100.0% |
| 2007 FY | 249 Thousand EUR | 39.11% |
| 2006 FY | 179 Thousand EUR | -26.03% |
| 2005 FY | 242 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Boiron SA | 96.76 Million EUR | 54.048% |
| Laboratorios Farmaceuticos Rovi, S.A. | 337.96 Million EUR | 86.843% |
| Vetoquinol SA | 103.53 Million EUR | 57.053% |
| AB Science S.A. | 336 Thousand EUR | -13133.929% |
| Nanobiotix S.A. | 200 Thousand EUR | -22133.0% |
| PHAXIAM Therapeutics S.A. | 671 Thousand EUR | -6526.826% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -4446599900.0% |
| BioSenic S.A. | - EUR | -Infinity% |
| ABIVAX Société Anonyme | 1.00 EUR | -4446599900.0% |
| Formycon AG | 467 Thousand EUR | -9421.627% |